These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38865057)

  • 1. MR beyond diagnostics at the ESMRMB annual meeting: MR theranostics and intervention.
    Hájek M; Flögel U; S Tavares AA; Nichelli L; Kennerley A; Kahn T; Futterer JJ; Firsiori A; Grüll H; Saha N; Couñago F; Aydogan DB; Caligiuri ME; Faber C; Bell LC; Figueiredo P; Vilanova JC; Santini F; Mekle R; Waiczies S
    MAGMA; 2024 Jul; 37(3):323-328. PubMed ID: 38865057
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction to: MR beyond diagnostics at the ESMRMB annual meeting: MR theranostics and intervention.
    Hájek M; Flögel U; S Tavares AA; Nichelli L; Kennerley A; Kahn T; Futterer JJ; Fitsiori A; Grüll H; Saha N; Couñago F; Aydogan DB; Caligiuri ME; Faber C; Bell LC; Figueiredo P; Vilanova JC; Santini F; Mekle R; Waiczies S
    MAGMA; 2024 Oct; 37(5):947-948. PubMed ID: 39312057
    [No Abstract]   [Full Text] [Related]  

  • 3. Smart magnetic resonance imaging-based theranostics for cancer.
    Brito B; Price TW; Gallo J; Bañobre-López M; Stasiuk GJ
    Theranostics; 2021; 11(18):8706-8737. PubMed ID: 34522208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics.
    Gan S; Lin Y; Feng Y; Shui L; Li H; Zhou G
    Int J Nanomedicine; 2018; 13():4263-4281. PubMed ID: 30087559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theranostics based on AIEgens.
    Wang D; Lee MMS; Xu W; Kwok RTK; Lam JWY; Tang BZ
    Theranostics; 2018; 8(18):4925-4956. PubMed ID: 30429878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Imaging, Therapy and Theranostics Based on Different Types of Functional Materials.
    Wu A
    Curr Med Chem; 2018; 25(25):2874-2875. PubMed ID: 30191774
    [No Abstract]   [Full Text] [Related]  

  • 7. Key Insights on the Classification and Theranostic Applications of Magnetic Resonance Imaging Contrast Agents.
    Kaur J; Sridharr M
    ChemMedChem; 2024 Apr; 19(8):e202300521. PubMed ID: 38246874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostics and metabolotheranostics for precision medicine in oncology.
    Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
    J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal-organic cage as a theranostic nanoplatform for magnetic resonance imaging guided chemodynamic therapy.
    Yin P; Sun D; Deng Y; Zhu X; Wang Y; Yang J; Feng X
    Theranostics; 2024; 14(12):4861-4873. PubMed ID: 39239515
    [No Abstract]   [Full Text] [Related]  

  • 10. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal-derived nanoparticles in tumor theranostics: Potential and limitations.
    Kuchur OA; Tsymbal SA; Shestovskaya MV; Serov NS; Dukhinova MS; Shtil AA
    J Inorg Biochem; 2020 Aug; 209():111117. PubMed ID: 32473483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-Nanoreactor-Assisted Synthesis of Semiconductor Nanocrystals for Efficient Cancer Theranostics.
    Yang T; Wang Y; Ke H; Wang Q; Lv X; Wu H; Tang Y; Yang X; Chen C; Zhao Y; Chen H
    Adv Mater; 2016 Jul; 28(28):5923-30. PubMed ID: 27165472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics.
    Ray S; Li Z; Hsu CH; Hwang LP; Lin YC; Chou PT; Lin YY
    Theranostics; 2018; 8(22):6322-6349. PubMed ID: 30613300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Medicine in Cancer Theranostics: Beyond the Target.
    Taïeb D; Hicks RJ; Pacak K
    J Nucl Med; 2016 Nov; 57(11):1659-1660. PubMed ID: 27445288
    [No Abstract]   [Full Text] [Related]  

  • 15. The potential use of theranostic bacteria in cancer.
    Azizian K; Pustokhina I; Ghanavati R; Hamblin MR; Amini A; Kouhsari E
    J Cell Physiol; 2021 Jun; 236(6):4184-4194. PubMed ID: 33174198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional gadolinium-based nanoscale systems for cancer theranostics.
    Li H; Zeng Y; Zhang H; Gu Z; Gong Q; Luo K
    J Control Release; 2021 Jan; 329():482-512. PubMed ID: 32898594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.
    Ehlerding EB; Grodzinski P; Cai W; Liu CH
    ACS Nano; 2018 Mar; 12(3):2106-2121. PubMed ID: 29462554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic Diagnostics.
    Ali MU; Chaudhary BN; Panja S; Gendelman HE
    Results Probl Cell Differ; 2024; 73():551-578. PubMed ID: 39242393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored ultra-small Prussian blue-based nanoparticles for MRI imaging and combined photothermal/photoacoustic theranostics.
    Fétiveau L; Paul G; Nicolas-Boluda A; Volatron J; George R; Laurent S; Muller R; Sancey L; Mejanelle P; Gloter A; Gazeau F; Catala L
    Chem Commun (Camb); 2019 Dec; 55(98):14844-14847. PubMed ID: 31768507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon Dots for In Vivo Bioimaging and Theranostics.
    Du J; Xu N; Fan J; Sun W; Peng X
    Small; 2019 Aug; 15(32):e1805087. PubMed ID: 30779301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.